• Research Topics

  Orphazyme Partnership for ALS Phase 3 Trial of Arimoclomol to Continue for Extension Phase

  Posted by ALS News Today Moderator on September 17, 2019 at 9:54 am

  

  Orphazyme said its work with Worldwide Clinical Trials will continue through the long-term extension of its ongoing Phase 3 study of oral arimoclomol. Read more here.

  What do you think of this news?

  ALS News Today Moderator replied 4 years, 7 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply